Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 2014; Volume 86,Issue 2

Articles

  • You have access
    Regulation of Human CYP2C9 Expression by Electrophilic Stress Involves Activator Protein 1 Activation and DNA Looping
    Ngome L. Makia, Sailesh Surapureddi, Katalin Monostory, Russell A. Prough and Joyce A. Goldstein
    Molecular Pharmacology August 2014, 86 (2) 125-137; DOI: https://doi.org/10.1124/mol.114.092585
  • You have access
    Label-Free Monitoring of μ-Opioid Receptor–Mediated Signaling
    Philippe Bourassa, Hanieh Bagheri Tudashki, Graciela Pineyro, Michel Grandbois and Louis Gendron
    Molecular Pharmacology August 2014, 86 (2) 138-149; DOI: https://doi.org/10.1124/mol.114.093450
  • You have access
    RETRACTION: Angiotensin II and Canonical Transient Receptor Potential-6 Activation Stimulate Release of a Signal Transducer and Activator of Transcription 3–Activating Factor from Mouse Podocytes
    Mousa Abkhezr and Stuart E. Dryer
    Molecular Pharmacology August 2014, 86 (2) 150-158; DOI: https://doi.org/10.1124/mol.114.092536
  • You have access
    Gating-Pore Currents Demonstrate Selective and Specific Modulation of Individual Sodium Channel Voltage-Sensors by Biological Toxins
    Yucheng Xiao, Kenneth Blumenthal and Theodore R. Cummins
    Molecular Pharmacology August 2014, 86 (2) 159-167; DOI: https://doi.org/10.1124/mol.114.092338
  • You have access
    A Novel Pathway for Arsenic Elimination: Human Multidrug Resistance Protein 4 (MRP4/ABCC4) Mediates Cellular Export of Dimethylarsinic Acid (DMAV) and the Diglutathione Conjugate of Monomethylarsonous Acid (MMAIII)
    Mayukh Banerjee, Michael W. Carew, Barbara A. Roggenbeck, Brayden D. Whitlock, Hua Naranmandura, X. Chris Le and Elaine M. Leslie
    Molecular Pharmacology August 2014, 86 (2) 168-179; DOI: https://doi.org/10.1124/mol.113.091314
  • You have access
    Molecular Mechanisms of Methoctramine Binding and Selectivity at Muscarinic Acetylcholine Receptors
    Jan Jakubík, Pavel Zimčík, Alena Randáková, Květoslava Fuksová, Esam E. El-Fakahany and Vladimír Doležal
    Molecular Pharmacology August 2014, 86 (2) 180-192; DOI: https://doi.org/10.1124/mol.114.093310
  • You have access
    Poisoning of Mitochondrial Topoisomerase I by Lamellarin D
    Salim Khiati, Yeonee Seol, Keli Agama, Ilaria Dalla Rosa, Surbhi Agrawal, Katherine Fesen, Hongliang Zhang, Keir C. Neuman and Yves Pommier
    Molecular Pharmacology August 2014, 86 (2) 193-199; DOI: https://doi.org/10.1124/mol.114.092833
  • You have access
    Complex Pharmacology of Novel Allosteric Free Fatty Acid 3 Receptor Ligands
    Brian D. Hudson, Elisabeth Christiansen, Hannah Murdoch, Laura Jenkins, Anders Højgaard Hansen, Ole Madsen, Trond Ulven and Graeme Milligan
    Molecular Pharmacology August 2014, 86 (2) 200-210; DOI: https://doi.org/10.1124/mol.114.093294
  • You have access
    Long-Term Channel Block Is Required to Inhibit Cellular Transformation by Human Ether-à-Go-Go–Related Gene (hERG1) Potassium Channels
    David M. Pier, George S. G. Shehatou, Susan Giblett, Christine E. Pullar, Derek J. Trezise, Catrin A. Pritchard, R. A. John Challiss and John S. Mitcheson
    Molecular Pharmacology August 2014, 86 (2) 211-221; DOI: https://doi.org/10.1124/mol.113.091439
  • You have access
    Modeling the Effects of β1-Adrenergic Receptor Blockers and Polymorphisms on Cardiac Myocyte Ca2+ Handling
    Robert K. Amanfu and Jeffrey J. Saucerman
    Molecular Pharmacology August 2014, 86 (2) 222-230; DOI: https://doi.org/10.1124/mol.113.090951
  • You have access
    Identification and Characterization of Novel Inhibitors of Mammalian Aspartyl Aminopeptidase
    Yuanyuan Chen, Hong Tang, William Seibel, Ruben Papoian, Ki Oh, Xiaoyu Li, Jianye Zhang, Marcin Golczak, Krzysztof Palczewski and Philip D. Kiser
    Molecular Pharmacology August 2014, 86 (2) 231-242; DOI: https://doi.org/10.1124/mol.114.093070
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 86 (2)
Molecular Pharmacology
Vol. 86, Issue 2
1 Aug 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics